DE69839265D1 - Modulatoren der expression von morphogenen und deren identifizierungsverfahren - Google Patents

Modulatoren der expression von morphogenen und deren identifizierungsverfahren

Info

Publication number
DE69839265D1
DE69839265D1 DE69839265T DE69839265T DE69839265D1 DE 69839265 D1 DE69839265 D1 DE 69839265D1 DE 69839265 T DE69839265 T DE 69839265T DE 69839265 T DE69839265 T DE 69839265T DE 69839265 D1 DE69839265 D1 DE 69839265D1
Authority
DE
Germany
Prior art keywords
exporation
morphogens
modulators
identification method
specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69839265T
Other languages
English (en)
Inventor
Haimanti Dorai
Alyssa A Shepard
Kuber T Sampath
Herman Oppermann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Curis Inc
Original Assignee
Curis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curis Inc filed Critical Curis Inc
Application granted granted Critical
Publication of DE69839265D1 publication Critical patent/DE69839265D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/30—Vector systems having a special element relevant for transcription being an enhancer not forming part of the promoter region
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Holo Graphy (AREA)
  • Liquid Crystal (AREA)
  • Indexing, Searching, Synchronizing, And The Amount Of Synchronization Travel Of Record Carriers (AREA)
DE69839265T 1997-05-29 1998-05-28 Modulatoren der expression von morphogenen und deren identifizierungsverfahren Expired - Lifetime DE69839265D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4791197P 1997-05-29 1997-05-29
PCT/US1998/011025 WO1998054344A2 (en) 1997-05-29 1998-05-28 Modulators of morphogen expression and methods of identifying the same

Publications (1)

Publication Number Publication Date
DE69839265D1 true DE69839265D1 (de) 2008-04-30

Family

ID=21951710

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69839265T Expired - Lifetime DE69839265D1 (de) 1997-05-29 1998-05-28 Modulatoren der expression von morphogenen und deren identifizierungsverfahren

Country Status (8)

Country Link
US (2) US6828095B1 (de)
EP (1) EP0985045B1 (de)
JP (1) JP2001517092A (de)
AT (1) ATE389727T1 (de)
AU (1) AU745514B2 (de)
CA (1) CA2291510A1 (de)
DE (1) DE69839265D1 (de)
WO (1) WO1998054344A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11313675A (ja) * 1998-04-30 1999-11-16 Hoechst Marion Roussel Kk ヒトｂｍｐ−７プロモーターおよびこれを用いた骨関連物質の探索法
US6368787B1 (en) * 1999-12-16 2002-04-09 Stryker Corporation Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements
CN1320618A (zh) * 2000-04-27 2001-11-07 上海博德基因开发有限公司 一种新的多肽——人Pax蛋白12.5和编码这种多肽的多核苷酸
CN1321664A (zh) * 2000-04-29 2001-11-14 上海博德基因开发有限公司 一种新的多肽——人Pax蛋白23和编码这种多肽的多核苷酸
CN1322755A (zh) * 2000-05-09 2001-11-21 上海博德基因开发有限公司 一种新的多肽——人Pax蛋白9和编码这种多肽的多核苷酸

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641743A (en) * 1988-01-25 1997-06-24 American Cyanamid Company Therapeutic compositions and methods for use of heparin-binding brain mitogens
WO1992007072A1 (en) * 1990-10-10 1992-04-30 La Jolla Cancer Research Foundation Method of inhibiting transcription utilizing nuclear receptors
US5169837A (en) * 1991-03-28 1992-12-08 Allelix Biopharmaceuticals Inc. Isolated osteogenic factor
US6071695A (en) * 1992-02-21 2000-06-06 Creative Biomolecules, Inc. Methods and products for identification of modulators of osteogenic protein-1 gene expression
AU703445B2 (en) 1994-06-07 1999-03-25 Stryker Corporation Methods and compositions for modulating morphogenic protein expression
US6083690A (en) 1995-06-02 2000-07-04 Osteoscreen, Inc. Methods and compositions for identifying osteogenic agents

Also Published As

Publication number Publication date
EP0985045B1 (de) 2008-03-19
ATE389727T1 (de) 2008-04-15
WO1998054344A2 (en) 1998-12-03
JP2001517092A (ja) 2001-10-02
EP0985045A2 (de) 2000-03-15
AU745514B2 (en) 2002-03-21
CA2291510A1 (en) 1998-12-03
WO1998054344A3 (en) 1999-02-25
US6828095B1 (en) 2004-12-07
AU7707398A (en) 1998-12-30
US20050208533A1 (en) 2005-09-22

Similar Documents

Publication Publication Date Title
DE69626015D1 (de) Verfahren zur identifizierung von knochenwachstum modulatoren
ATE176468T1 (de) Verfahren zur racemisierung von enantiomeren der alpha-liponsäure
ATE345682T1 (de) In vitro verfahren zum einbringen von nukleinsäuren in eine zelle
ATE428780T1 (de) Verfahren zur zubereitung von antisense oligonukleotiden
DE69637726D1 (de) Gruppen zum einfangen von nukleinsäuren
DE60040335D1 (de) Derivatisierte nukleinsäuren und deren verwendung
DE69534855D1 (de) Enzymaktive dna moleküle
ATE248150T1 (de) Lactam-enthaltende hydroxamsäure-derivate, deren herstellung und deren verwendung als inhibitoren von matrix-metalloproteasen
ATE352639T1 (de) Antisense modulation der expression von integrin alpha 4
DE69432787D1 (de) Klonierung von Enterokinase und Verfahren zu deren Verwendung
ATE280947T1 (de) Funktionelle fragmente des hiv-1 vpr proteins and eine methode zu seiner anwendung
DE69823372T8 (de) Verfahren und reagentiensatz zur amplifizierung, sequenzierung und typisierung von hla i genen
DE68901878D1 (de) Verfahren zur faerbung von nichtradioaktiven markierten nukleinsaeuren und zusammensetzung zum gebrauch in diesem verfahren.
ATE373083T1 (de) Methode und zusammensetzungen zur identifizierung von morphogen-analogen
DE69928395D1 (de) Cyclin-e2 proteine und dafür kodierende gene
DE69839265D1 (de) Modulatoren der expression von morphogenen und deren identifizierungsverfahren
DE69835813D1 (de) Verfahren zur kultivierung von zellen und zur vermehrung von viren
DE19781038T1 (de) Keratinozytenwachstumsfaktor-2-Produkte
DK0840802T3 (da) Fremgangsmåde til sekvensering gennem oligomerhybridisering
ATE316138T1 (de) Rekombinante expression von s-layer-proteinen
DE68923979D1 (de) Verfahren und Satz zur Identifizierung von Bakterien unter Verwendung von chromosomaler DNS.
DE69803193T2 (de) Verfahren zum Screenen von Interaktionen zwischen Transkriptionsfaktoren und Koaktivatoren
BR9810643A (pt) Genes e proteìnas de telomerase de vertebrado, eutilização dos mesmos
AR019865A1 (es) Metodo para modular la expresion de genes exogenos o heterologos, y uso de un ligando no esteroide en dicho metodo.
NZ501962A (en) Vertebrate telomerase genes and proteins and uses thereof

Legal Events

Date Code Title Description
8372 Publication of ep patent withdrawn